A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 263-268

  Cook, Sharlene A ^a   MacLaughlin, Helen ^a   Macdougall, Iain C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anti obesity agents; Chronic kidney disease; Exercise training; Orlistat; Transplantation; Weight reduction

Indexed keywords

ANTIOBESITY AGENT; TETRAHYDROLIPSTATIN; LACTONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG WITHDRAWAL; EXERCISE; EXERCISE TEST; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOW FAT DIET; MALE; OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; CHRONIC DISEASE; DIET THERAPY; KINESIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PATIENT CARE;

ADULT; ANTI-OBESITY AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; HUMANS; KIDNEY DISEASES; LACTONES; MALE; MIDDLE AGED; OBESITY; PATIENT CARE TEAM; WEIGHT LOSS;

EID: 44449132684     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm511     Document Type: Article

References (20)

1. Johansen K, Kutner N, Young B, Kaysen G. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332
2. Byers T. Body weight and mortality. N Engl J Med 1995; 333: 723-724
3. Meier-Kreische HU, Arndorfer JA, Kaplan B. The impact of body mass index on transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73: 70-74
4. De Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Rel Metab Dis 2002; 26 [Suppl 4]: S21-S24
5. Hsu C, McCulloch C, Iribarren C, Darbinian J, Go A. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
6. Naish P. Physical dysfunctioning - the case for rehabilitation. Br J Renal Med 1999; 4: 6-8
7. Johansen K, Kutner N, Young B, Chertow G. Association of body size with health staus in patients beginning dialysis. Am J Clin Nutr 2006; 83: 543-549
8. Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 1981; 304: 309-313
9. Davidson M, Hauptman J, DiGirolamo M et al. Weight control and risk factor reduction in obese subjects treated for 2 years with Orlistat. JAMA 1999; 281: 235-242
10. Maclaughlin H, Cook S, Macdougall IC et al. Beneficial effects of a structured weight management programme involving diet, exercise and orlistat in obese, diabetic patients with chronic kidney disease. Diabetes Obesity Metab 2007(in press)
11. VanSwearingen JM, Brach JS. Making geriatric assessments work: selecting useful measures. Phys Ther 2001; 81: 1233-1252
12. Ritchie C, Trost SG, Brown W, Armit C. Reliability and validity of physical fitness field tests for adults aged 55 to 70 years. J Sci Med Sport 2005; 8: 61-70
13. Eston R, Thompson M. Use of ratings of perceived exertion for predicting maximal work rate and prescribing exercise intensity in patients taking atenelol. Br J Sport Med 1997; 31: 114-119
14. Hlatky MA, Boineau RE, Higginbotham MB et al. A brief self-administered questionnaire to determine functional cpacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 651-654
15. Broom I, Wilding J, Stott P, Myers N. UK multimorbidity study group. Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients. Int J Clin Pract 2002; 56: 494-499
16. You T, Murphy K, Lyles M, Demons J, Lenchik L, Nicklas B. Addition of aerobic exercise to dietary weight loss preferentially reduces abdominal adipocyte size. Int J Obesity 2006; 30: 1211-1216
17. Hollis J, Corden E, Williams P. Longitudinal evaluation of a weight reduction programme for patients on peritoneal dialysis. Peritoneal Dial Int 2005; 25: S152-S154
18. Painter P. End stage renal disease. In: Skinner JS, ed. Exercise Testing and Exercise Prescription for Special Cases. Theoretical Basis and Clinical Application, Chapter 20, 2nd edn, Lipincott, Williams & Wilkins, USA: 1993351-362,
19. Kouidi E, Albani M, Natsis K et al. The effect of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 685-699
20. Moore G, Parsons D, Stray-Gunderson J, Painter P, Brinker K, Mitchell J. Uremic myopathy limits aerobic capacity in haemodialysis patients. Am J Kidney Dis 1993; 22: 277-287